Saul Hadassin
Stock Analyst at UBS
(1.82)
# 1,852
Out of 4,479 analysts
5
Total ratings
75%
Success rate
16.74%
Average return
Main Sectors:
Top Industries:
1 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Neutral | $175 → $180 | $186.94 | -3.71% | 5 | Jan 25, 2024 |
ResMed
Jan 25, 2024
Maintains: Neutral
Price Target: $175 → $180
Current: $186.94
Upside: -3.71%